Status:
TERMINATED
The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Doctors Kienle Center for Humanistic Medicine/Penn State College of Medicine
Conditions:
Nausea
Vomiting
Eligibility:
All Genders
21-89 years
Phase:
NA
Brief Summary
This study is a three group, randomized, double blind, placebo-controlled trial with two repeated measurements. The same measurements will be collected for each participant during two consecutive chem...
Detailed Description
This study is a three group, randomized, double blind, placebo-controlled trial with two repeated measurements. The same measurements will be collected for each participant during two consecutive chem...
Eligibility Criteria
Inclusion
- Men and women included
- Ages between 21 years old and 89 years old
- Diagnosis of breast cancer - all histologies and stages
- Subjects must have reported some degree of nausea following chemotherapy
- Subjects must have at least two remaining cycles of chemotherapy to complete
- Subjects must be fluent in English or Spanish
- Subjects must be willing to complete questionnaire through follow-up phone calls
- Subjects must be able to use the pocket diffuser
Exclusion
- Inability to sign the consent
- Pregnancy
- Cognitive impairment
- Current use of aromatherapy for symptom management or prevention
- Allergies to peppermint, ginger, or vanilla
- Concurrent radiation therapy
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04478630
Start Date
August 30 2021
End Date
February 18 2023
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Cancer Institute
Hershey, Pennsylvania, United States, 17033